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Abstract 15 
Background: To examine associations between physical activity (PA) and depressive 16 
symptoms among adults with type 2 diabetes mellitus (Type 2 DM), and whether associations 17 
varied according to weight status. 18 
Methods: Diabetes MILES – Australia is a national survey of adults with diabetes, focused on 19 
behavioral and psychosocial issues. Data from 705 respondents with Type 2 DM were 20 
analyzed, including: demographic and clinical characteristics, PA (IPAQ-SF), depressive 21 
symptoms (PHQ-9), and BMI (self-reported height and weight). Data analysis was performed 22 
using ANCOVA.  23 
Results: Respondents were aged 59±8 years; 50% women. PA was negatively associated with 24 
depressive symptoms for the overall sample (ηp2= 0.04,p<0.001) and all weight categories 25 
separately: healthy (ηp2 0.11, p=0.041, ), overweight (ηp2= 0.04, p =0.025) and obese 26 
(ηp2=0.03, p=0.007,). For people who were healthy (BMI 18.5-24.9) or overweight (BMI 25-27 
29.9), high amounts of PA were significantly associated with fewer depressive symptoms; for 28 
adults who were obese (BMI ≥ 30) however, both moderate and high amounts were 29 
associated with fewer depressive symptoms.  30 
Conclusions: PA is associated with fewer depressive symptoms among adults with Type 31 
2DM, however the amount of PA associated with fewer depressive symptoms varies 32 
according to weight status. Lower amounts of PA might be required for people who are obese 33 
to achieve meaningful reductions in depressive symptoms compared to those who are healthy 34 
weight or overweight. Further research is needed to establish the direction of the relationship 35 
between PA and depressive symptoms.  36 
 37 
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Introduction 39 
 40 
The associations between physical activity (PA) and depressive symptoms have been 41 
examined extensively in the general population and show that PA is associated with fewer 42 
depressive symptoms1,2. There is also emerging evidence in the general population that the 43 
associations between PA and depressive symptoms vary according to whether the person is of 44 
healthy weight, overweight or obese 3. These associations, however, have not been explored 45 
thoroughly among people with Type 2 D 4,5.  46 
 47 
Diabetes is a global epidemic 6, projected to affect up to 3 million Australians over the age of 48 
25 years by 2025 7. Around 85% of diabetes is accounted for by Type 2 diabetes mellitus 49 
(Type 2 DM) 7. People with Type 2 DM are two to three times more likely to experience 50 
depressive symptoms compared to the general population 8,9.  In addition to being associated 51 
with lower physical and mental functioning 5,10 and lower quality of life 11, depressive 52 
symptoms are also associated with increased/higher risk for suboptimal glycaemic control, 53 
diabetes-related complications 12, increased/higher health service use 10, and higher mortality 54 
rates 13. Examining factors, including PA that might be associated with higher or lower levels 55 
of depressive symptoms among people with Type 2 DM is vital to inform healthcare practices 56 
and the development of tailored interventions. 57 
 58 
PA is a central component of the self-management regimen for people with Type 2 DM, and 59 
thus associations with depressive symptoms are likely to be more complex than for other 60 
population groups 14. A small body of research has shown an inverse association between 61 
depressive symptoms and participation in PA among people with Type 2 DM 4,15,16.  These 62 
associations require further investigation, specifically, including the role of weight status. An 63 
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examination of the  associations between PA, depressive symptoms and weight status among 64 
adults with Type 2 DM is needed because people with Type 2 DM have a high incidence of 65 
overweight and obesity 17, and a recent study from the Diabetes MILES-Australia dataset 66 
(also used in the current study) showed that higher body mass index (BMI) is associated with 67 
greater symptoms of depression among people with Type 2 DM 12. 68 
 69 
The purpose of this study was to provide further understanding of the associations between 70 
PA, depressive symptoms and weight status in Type 2 DM. Specifically, the aims of this 71 
study were to assess, in a large, population-based sample of adults with Type 2 DM: (1) the 72 
associations between PA and depressive symptoms; and (2) whether associations between PA 73 
and depressive symptoms varied according to weight status. 74 
 75 
Methods 76 
Study Design 77 
Data was collected in 2011 as part of the Diabetes MILES (Management and Impact for 78 
Long-term Empowerment and Success) – Australia study.  Diabetes MILES – Australia is a 79 
large, national survey of adults living with Type 1 or Type 2 DM, which aims to examine the 80 
psychological, behavioral and social factors relevant to living diabetes. The study protocol 81 
and sample characteristics are described in detail elsewhere 18.  82 
 83 
Briefly, the Diabetes MILES – Australia survey was distributed by post to a random sample 84 
of 15,000 registrants of the National Diabetes Services Scheme (NDSS), and made the survey 85 
available online. Eligibility criteria were living with Type 1 or Type 2 DM, aged 18 to 70 86 
years, living in Australia, and able to complete the survey in English without assistance. In 87 
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total, 3,338 eligible respondents completed the survey.  Several survey versions were used in 88 
order to tailor content to diabetes type and treatment, and to reduce respondent burden (not all 89 
scales/items appeared in all versions). .  90 
 91 
Ethics approval was granted by the Deakin University Human Research Ethics Committee 92 
(2011-046). 93 
Measures 94 
Demographic and Clinical Variables 95 
Demographic variables included gender, age, relationship status, highest level of education, 96 
country of birth, and annual household income. Clinical data extracted for this study were 97 
diabetes duration, insulin treatment (yes/no), co-morbidities and height and weight (for 98 
calculation of BMI). For the co-morbidities item, respondents were asked if they have a range 99 
of health conditions, for example, coeliac disease, fatty liver disease, heart disease / heart 100 
attack, high blood pressure (hypertension). The number of comorbidities that respondents 101 
reported was summed to represent the total number of comorbidities. All data were collected 102 
by self-report.  103 
 104 
Depressive symptoms 105 
Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), 106 
which is the depression module of the self-administered version of the PRIME-MD 107 
diagnostic instrument for common mental disorders. Respondents rated their experience of 108 
each of the nine DSM-IV criteria (i.e. depressed mood or irritable; decreased interest or 109 
pleasure in most activities; significant weight change or change in appetite; change in sleep; 110 
change in activity; fatigue or loss of energy; guilt/worthlessness; diminished ability to think 111 
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or concentrate; suicidality)   as “0” (not at all) to “3” (nearly every day) 19. Item scores were 112 
summed to form a total score (range: 0-27), with higher scores indicating higher levels of 113 
depressive symptoms. Total scores of ≥10 indicate moderate-to-severe depressive symptoms 114 
19. The PHQ-9 has been validated in a range of population groups 19-21. For example, in a 115 
study of 6,000 patients, increased PHQ-9 depression severity was associated with a 116 
substantial decrease in functional status on all 6 Short-Form General Health 20 subscales, and 117 
increases in symptom-related difficulty, sick days, and health care utilization. In a study of 118 
580 patients, where scores on the PHQ-9 were compared with independent structured mental 119 
health professional interviews, a PHQ-9 score ≥10 had a sensitivity of 88% and a specificity 120 
of 88% for major depression19.  Among people with diabetes, , the PHQ-9  was an efficient 121 
and well-received screening instrument for major depressive disorders in a sample of patients 122 
in a specialized outpatient clinic 22. For the current study, total score for depressive symptoms 123 
was the outcome variable. 124 
Participation in physical activity  125 
PA was assessed using the International Physical Activity Questionnaire Short Form (IPAQ-126 
SF) 23. The IPAQ-SF encompasses PA across all domains (including leisure, work and 127 
household chores) at three intensity levels: 1) vigorous, 2) moderate, and 3) walking. Studies 128 
of the measurement properties of the IPAQ across 12-countries demonstrated that the IPAQ 129 
instruments have acceptable measurement properties, at least as good as other established 130 
self-reports. IPAQ-SF had fair to moderate agreement with accelerometer-measured physical 131 
activity (pooled r = .30) and repeatability was at an acceptable level, with 75% of the 132 
correlation coefficients observed above 0.65 and ranging from 0.88 to 0.3223. The IPAQ-SF 133 
has also been used in other studies of adults with Type 2 DM24. Data were cleaned according 134 
to the data processing rules provided by the IPAQ developers 25. 135 
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 136 
Amount of PA was categorised as ‘high’, ‘moderate’ and ‘low’, consistent with the IPAQ-SF 137 
guidelines. These categories incorporate total metabolic equivalent (MET)/minutes per week 138 
as well as the number of days/sessions of PA. Total MET minutes were calculated by 139 
multiplying the minutes per week of walking, moderate-intensity PA and vigorous-intensity 140 
PA by 3.3, 4.0 and 8.0, respectively. The criteria for the three levels take into account that the 141 
questions in the IPAQ assess PA in all domains of daily life, resulting in higher median 142 
MET-minutes estimates than those estimated from leisure-time participation alone. The 143 
‘high’ category represents a minimum of one hour moderate-intensity activity over and above 144 
the basal level of activity daily, or at least 30 minutes of vigorous-intensity activity over and 145 
above basal levels daily (basal activity was considered to be equivalent to approximately 146 
5000 steps per day).. This level is equivalent to population targets for health-enhancing PA 147 
when multi-domain instruments, such as IPAQ, are used 25. The ‘moderate’ category is 148 
defined as doing some activity, more than the low active category, and is equivalent to half an 149 
hour of at least moderate-intensity PA on most days.  The ‘low’ category is defined as not 150 
meeting any of the criteria for either of the previous categories 25.  151 
 152 
Body Mass Index (BMI) 153 
BMI was calculated using respondents’ self-reported weight, in kilograms, divided by the 154 
square of their self-reported height, in metres. BMI was then categorised based on World 155 
Health Organisation recommendations, with a BMI of 18.5-24.9 being considered healthy 156 
weight; 25-29.9 considered overweight; and ≥30 considered obese.  157 
 158 
  Physical activity and depressive symptoms 
 
8 
 
Data Analysis  159 
The present study used data from a randomly selected sub-sample of participants with Type 2 160 
DM who received the MILES-Australia survey version that contained scales/items about PA 161 
(n= 862). Analyses were performed on cases with valid and complete data and calculated 162 
scores for depressive symptoms if respondents had one or fewer missing data points on the 163 
PHQ-9 (with missing data imputed), otherwise the case was declared as missing. Cases with 164 
missing or invalid data for key variables (i.e. PA, BMI and depressive symptoms) were 165 
removed from the dataset prior to analysis; resulting in 705 valid cases). Demographic and 166 
clinical characteristics of cases included in the analysis were compared with those that were 167 
not included (due to missing or invalid data). There were no significant differences in any 168 
demographic or clinical characteristics examined except level of education (p =0.045), with 169 
those who had a university degree more likely to have valid answers for all items. For all 170 
other variables included in the analyses, missing data were minimal (0-1.0%), except annual 171 
household income and level of education, which had 5.2% and 5.7% of missing data, 172 
respectively.  173 
 174 
Univariate analyses (Pearson correlation coefficients and t-tests) were performed to examine 175 
associations between demographics, clinical characteristics and depressive symptoms. The 176 
following variables were dichotomised: relationship status (partner versus no partner), level 177 
of education (less than university degree versus university degree and above), country of birth 178 
(Australian born versus born overseas), annual household income (≤$60,000 versus 179 
≥$60,001). We included variables significant at 0.05 level in subsequent analyses. 180 
 181 
For the main analysis, a series of ANCOVA analyses were conducted. First, an analysis of 182 
the associations between PA and depressive symptoms, unadjusted for covariates was 183 
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conducted. Following this, the overall association between amount of PA (low, moderate and 184 
high) and depressive symptoms, after controlling for covariates (i.e., co-morbidities, BMI, 185 
age [negative], income [negative], education level [negative], being single, and using insulin), 186 
were examined. A subsequent analyses according to weight status was conducted  to 187 
determine whether being of healthy weight, overweight and obese had a modifying effect 188 
(BMI was not controlled for in these analyses and people who were underweight (n = 3) were 189 
not included in this analysis 26). We used post hoc Bonferroni pairwise comparisons to 190 
examine significant differences between PA categories for analyses where a main effect of 191 
PA was significant. Mean differences reported are the adjusted mean differences after 192 
controlling for covariates in the models.  Differences were considered statistically significant 193 
at p <0.05.  194 
 195 
Results 196 
 197 
Sample characteristics 198 
Respondents’ age ranged from 23 to 70 years, with a mean of 59±8 years, and 50% of 199 
respondents were women (n=351). Most respondents were born in Australia (n=516, 73%), 200 
and were either married or in a de facto relationship (i.e., living with another person as a 201 
couple; n=510, 73%); 25% (n=166) reported a diploma/certificate as their highest level of 202 
education, and a further 19% (n=123) had completed secondary school; almost half reported 203 
an annual household income ≤$40,000 ($20,001-$40,000: n=163, 24%; ≤$20,000: n=147, 204 
22%). Respondents had been living with Type 2 DM for 8.5±6.7 years; 32% (n=227) were 205 
using insulin to manage their condition and respondents reported a mean of 2.6±2.2 co-206 
morbidities. See Table 1. 207 
 208 
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Table 1 here 209 
 210 
 Depressive symptoms, weight status and physical activity 211 
  212 
Respondents’ depressive symptom scores ranged from 0-27, with a mean of 6.6±6.0; 28% 213 
(n=195) of the sample had moderate-to-severe depressive symptoms. Respondents’ BMI 214 
ranged from 14.6 to 94.3, with a mean of 32.6±7.8; 30% (n=214) of the sample were 215 
overweight and 59% (n=418) were obese. In terms of volume of PA, 29% (n=203) reported 216 
low levels of PA, 34% (n=237) reported moderate levels and 38% (n=265) reported high 217 
levels. See Table 2. 218 
 219 
Table 2 here 220 
 221 
Associations with depressive symptoms: univariate analyses  222 
 223 
Depressive symptoms were associated positively with the number of co-morbidities (r = 224 
0.382, p<0.001) and BMI (r = 0.14, p <0.001) and negatively with age (r = -0.13, p =0.003). 225 
T-test showed that higher depressive symptoms were associated with having a lower income 226 
(t= 2.441, p=0.015), a lower education level (t = 2.78, p =0.006), being single (t = 3.045, p 227 
=0.002), and using insulin (t = -3.27, p = 0.001). Each of these factors were included as 228 
covariates in subsequent ANCOVA.  229 
 230 
Association between PA and depressive symptoms 231 
The unadjusted analyses are shown in Table 3. The following results refer to the analyses that 232 
were adjusted for covariates. First, the overall association between PA and depressive 233 
symptoms were examined (see Table 4). The ANCOVA model was significant and explained 234 
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22% of the variance in depressive symptoms. PA was significant and had a medium effect 235 
size, controlling for other covariates in the model. There was a significant difference in 236 
depressive symptoms between low and moderate amounts of PA (mean diff = 1.87, p=0.002, 237 
95% CI = 0.585 to 3.153) and low and high amounts of PA (mean diff = 2.55, p = <0.001, 238 
95% CI = 1.268 to 3.824), however the difference between moderate and high amounts of PA 239 
was not significant (p = 0.531; 95% CI = -.525 to 1.878). These analyses show that moderate 240 
and high amounts of PA, compared to low amounts, were associated with fewer depressive 241 
symptoms. 242 
Table 3 here 243 
 244 
Table 4 here 245 
 246 
 247 
For people of healthy weight, the ANCOVA model was significant and explained 29% of the 248 
variance in depressive symptoms. PA was significant after controlling for covariates and had 249 
a moderate effect size. There were significant differences in depressive symptoms between 250 
low and high PA (mean diff = 3.99, p=0.036, 95% CI = 0.199 to 7.773) but no significant 251 
difference between low and moderate amounts of PA (p=0.270, 95% CI = -1.261 to 7.102) or 252 
moderate and high amounts of PA (p=1.0, 95% CI = -2.500 to 4.631). These results suggest 253 
that high volumes of PAare associated with fewer depressive symptoms for people of healthy 254 
weight.  255 
 256 
For people who are overweight, the ANCOVA model was significant and explained 16% of 257 
the variance in depressive symptoms. PA was significant after controlling for covariates and 258 
had a moderate effect size. There were significant differences in depressive symptoms 259 
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between low and high PA (mean difference = 2.79, p=0.024, 95% CI = 0.282 to 5.297) but no 260 
significant differences between low and moderate amounts PA (p=0.469, 95% CI = -1.029 to 261 
3.979) or moderate to high amounts of PA (p=0.338, 95% CI = -0.677 to 3.305). Similar to 262 
people of healthy weight, these results suggest that, for people who are overweight, high 263 
amounts of PA, are associated with fewer depressive symptoms. 264 
 265 
For people who are obese, the ANCOVA model was significant and explained 21% of the 266 
variance in depressive symptoms. PA was significant after controlling for covariates and had 267 
a medium effect size. There was a significant difference in depressive symptoms between low 268 
and moderate amounts of PA (mean diff = 1.786, p=0.034, 95% CI = 0.101 to 3.471) and low 269 
and high amounts of PA (mean diff = 2.055, p=0.012, 95% CI = 0.345 to 3.765) but not 270 
between moderate and high amounts of PA (p=1.0, 95% CI = -1.422 to 1.960). These results 271 
suggest that for people who are obese, moderate and high amounts of PAare associated with 272 
fewer depressive symptoms.  273 
 274 
Figure 1 shows the associations between amount of PA and depressive symptoms for each 275 
weight classification (i.e., healthy weight, overweight and obese). 276 
 277 
Figure 1 here 278 
Discussion 279 
This study examined associations between PA and depressive symptoms, controlling for a 280 
range of potential covariates, among a large, population-based, sample of adults with Type 2 281 
DM. The findings suggest that associations between PA and depressive symptoms are 282 
complex; although PA was associated with fewer depressive symptoms, the amount of PA 283 
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that was associated with fewer depressive symptoms differed according to weight status.  284 
These findings present a range of avenues for future research in this area and have 285 
implications for the design of interventions that seek to reduce the burden of depressive 286 
symptoms and increase PA for people with Type 2 DM.  287 
 288 
The present findings support previous research indicating that PA is associated with fewer 289 
depressive symptoms among adults with Type 2 DM 15,16. The findings suggest that the 290 
amount of PA that is associated with lower depressive symptoms is equivalent to thirty 291 
minutes of moderate-intensity PA across all domains (e.g., active transport, household chores 292 
and leisure-time) on most days. Higher amounts of PA were not associated with additional 293 
declines in depressive symptoms above this level of participation. For the overall sample, 294 
after controlling for BMI, these findings suggested that PA, even at lower volumes than the 295 
recommended level for a physical health benefit 25, appears to be associated with fewer 296 
depressive symptoms. Other population-based research has shown that mental health benefits 297 
are associated with lower levels of PA than required for physical health 3,27. Given that most 298 
adults with Type 2 DM find it challenging to meet PA guidelines, a lower level of 299 
participation is likely to be more achievable for the majority of the population,  28, which is 300 
an encouraging finding.  301 
 302 
Interestingly, the findings of the current study indicate that the amount of PA associated with 303 
fewer depressive symptoms varied by weight status. For people in the healthy weight or 304 
overweight classification, a high amount of PA (equivalent to at least an hour or more of 305 
moderate-intensity activity, or thirty minutes of vigorous-intensity activity, on most days), 306 
was associated with fewer depressive symptoms. In contrast, for people in the obese 307 
classification, moderate amounts of PA were associated with fewer depressive symptoms and 308 
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there was no difference in depressive symptoms between moderate and high amounts of PA. 309 
These findings may, in part, be explained by the higher baseline depressive symptoms of 310 
people who are obese (mean depressive symptoms score for healthy, overweight and obese 311 
respondents was 5.5, 5.4, and 7.4, respectively) and a preference for lower intensity PA. 312 
Previously published findings from the Diabetes MILES – Australia study 12 showed that 313 
people with Type 2 DM who were severely obese were more likely to report moderate-severe 314 
depressive symptoms than matched controls (37% versus 27%). A systematic review of the 315 
effects of PA on depressive symptoms for people with chronic illness showed that PA had 316 
larger effects on depressive symptoms when baseline depressive symptoms were higher 29. 317 
Also, people who are obese experience stigma due to their weight and this is related to PA 318 
avoidance 30. Such stigma and feelings of self-consciousness are likely to be magnified when 319 
performing vigorous physical activities such as running and aerobics31,32, and thus it is 320 
possible that more moderate  levels of PA may be preferred by this group.  321 
 322 
The cross-sectional nature of this study precludes assessment of the directionality of the 323 
association between PA and depressive symptoms. It is likely that the association between 324 
PA and depressive symptoms is bi-directional 33; as well as the possibility of higher levels of 325 
PA reducing depressive symptoms, more depressive symptoms may lead to lower levels of 326 
PA. People with Type 2 DM and depressive symptoms are often physically inactive 5. 327 
Symptoms of depression include a lack of motivation and energy and increased apathy 34 and 328 
may thus act as a barrier to participation in PA among people with Type 2 DM. A recent 329 
study of healthy older adults, however, found that those with depressive symptoms responded 330 
well to an exercise intervention that incorporated  14 face-to-face counselling sessions over 4 331 
years designed to increase aerobic exercise.; half of those with depressive symptoms in the 332 
intervention group were able to maintain increased aerobic exercise during the four years of 333 
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follow-up35. Thus, interventions that reduce depressive symptoms might lead to increased PA 334 
in this group. Furthermore, the association between depression and increased risk of mortality 335 
among people with Type 2 DM 13 might be partly explained by low levels of participation in 336 
PA among people who are depressed. 337 
 338 
As well as BMI, a range of other socio-demographic and clinical factors were associated with 339 
depressive symptoms in our sample. Socio-demographic factors including being single, being 340 
younger, having a lower income, lower education level and clinical factors including the 341 
number of comorbidities and being treated with insulin, were associated significantly with 342 
depressive symptoms. These associations have been identified in other studies of people with 343 
diabetes36,37,38, suggesting that it is important that they are considered in future studies that 344 
aim to examine the independent association between behavioural or psycho-social factors and 345 
depressive symptoms among adults with Type 2 DM. These findings also suggest that some 346 
population groups, such as those with lower socio-economic status, are more likely to 347 
experience depressive symptoms, and should be a focus of interventions that aim to reduce 348 
depressive symptoms. 349 
 350 
Key strengths of this study are the large, population-based sample of adults with Type 2 DM 351 
and novel in-depth examination of the associations between PA, weight and depressive 352 
symptoms. The limitations of this study include the cross-sectional nature of the data, which 353 
means that causality cannot be implied by the findings. Self-report data were used to measure 354 
participation in PA as well as height and weight, which may result in social desirability bias. 355 
For large population-based studies, however, direct observation is not feasible and it is 356 
necessary to rely on self-report. Furthermore, the associations examined were less impacted 357 
by any self-report bias than would be the case if examining the effect of an intervention,  the 358 
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measure of PA used in this study has adequate reliability and validity 23, and self-report 359 
height and weight has been shown to accurately identify weight categories39. We categorized 360 
PA according to the IPAQ-SF guidelines, however, a limitation of this approach is that these 361 
categories do not allow independent examination of the frequency or intensity of PA and 362 
future research should examine the impact of these on depressive symptoms among people 363 
with Type 2 DM. Limitations of the broader MILES study are also applicable to the current 364 
study and have been described in detail previously 18 . 365 
 366 
In conclusion, this study advances current knowledge on associations between PA, weight 367 
status and depressive symptoms among people with Type 2 DM. The findings suggest that 368 
even moderate amounts of PA are associated with fewer depressive symptoms. Therefore, 369 
improving participation in PA may lead to decline in depressive symptoms, or a reduction in 370 
depressive symptoms may help to improve participation in PA. The role of weight status 371 
needs further examination in future studies to test the robustness of these findings concerning 372 
the levels of PA that are associated with fewer depressive symptoms among people in 373 
different weight categories. 374 
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Table 1: Demographic and clinical characteristics of sample 493 
  N Mean / n SD / % 
Gender 700 
  
Women 
 
351 50.1 
Age 703 58.9 8.3 
Relationship status 700 
  
Single 
 
71 10.1 
In steady relationship 
 
7 1.0 
Married/defacto 
 
510 72.9 
Separated 
 
25 3.6 
Divorced 
 
64 9.1 
Widowed 
 
23 3.3 
Education (highest level) 665 
  
No formal qualifications 
 
67 10.1 
School/intermediate certificate 
 
96 14.4 
High school/leaving certificate 
 
123 18.5 
Trade/apprenticeship 
 
68 10.2 
Certificate/diploma 
 
166 25.0 
University degree 
 
95 14.3 
Higher university degree 
 
50 7.5 
Household Income (annual) 668 
  
Up to $20,000 
 
147 22.0 
$20,001-40,000 
 
163 24.4 
$40,001-60,000 
 
142 21.3 
$60,001-100,000 
 
128 19.2 
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$100,101-150,000 
 
55 8.2 
$150,001 or more 
 
33 4.9 
Country of birth 705 
  
Australia 
 
516 73.2 
Other 
 
189 26.8 
Diabetes duration - years since diagnosis 698 8.5 6.7 
Diabetes management  700 
  
Diet / lifestyle only 
 
124 17.7 
Oral medication  338 48.3 
Insulin 
 
227 32.2 
      Non-insulin injectables  11 1.6 
Co-morbidities  705 2.6 2.2 
    
 494 
 495 
  496 
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 497 
Table 2 Main Study Variables Descriptive Statistics 498 
         N Mean / n SD / % 
Depressive symptoms  
PHQ-9 total 705 6.6 6.0 
Moderate-to-severe depressive symptoms 
(PHQ-9 total ≥10)  195 28 
Body mass index 705 32.6 7.8 
Weight Status 705 
  
Underweight 
 
3 0.4 
Healthy weight 
 
70 9.9 
Overweight 
 
214 30.4 
Obese 
 
418 59.3 
Physical Activity 705   
Low  203 28.8 
Medium  237 33.6 
High  265 37.6 
 499 
  500 
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Table 3 Depressive Symptoms by Volume of Physical Activity (Unadjusted ANCOVA)  501 
  502 
  SS  df MS F P ηp2 
Whole Sample 
      
Volume of Physical 
Activity 1577.60 2 788.80 23.66 <0.001 0.06 
Error  23403.63 702 33.34 
   
Total  55546.00 705 
    
R2= .06 (Adjusted R2= .06) 
   
Healthy Weight 
      
Volume of Physical 
Activity 229.77 2 114.89 3.76 0.028 0.10 
Error  2047.72 67 30.56 
   
Total  4384.00 70 
    
R2= .101 (Adjusted R Squared = .074) 
   
Overweight 
      
Volume of Physical 
Activity 309.10 2 154.55 5.49 0.005 0.05 
Error  5941.71 211 28.16 
   
Total  12463.00 214 
    
R2= .05 (Adjusted R2= .04) 
   
Obese 
      
Volume of Physical 
Activity 863.96 2 431.98 12.06 <0.001 .06 
Error  14867.30 415 35.83 
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Total  38426.00 418 
    
R2= .06 (Adjusted R2= .05) 
   
       
MS = Mean Square; SS = Sum of squares 
 503 
 504 
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Table 4 Depressive Symptoms by Volume of Physical Activity (ANCOVA adjusted for 506 
covariates)  507 
  SS  df MS F P ηp2 
Whole Sample 
      
Volume of Physical 
Activity 650.78 2 325.39 11.81  <0.001 0.04 
Error  16910.76 614 27.54 
   
Total  48577.00 624 
    
R2 = .23 (Adjusted R2 = .22) 
   
Healthy Weight 
      
Volume of Physical 
Activity 157.56 2 77.78 3.40 0.041 0.11 
Error  1250.96 54 23.17 
   
Total  3943.00 63 
    
R2= .38 (Adjusted R2= .29) 
   
Overweight 
      
Volume of Physical 
Activity 188.77 2 94.37 3.78 0.025 0.04 
Error  4525.66 181 25.00 
   
Total  11217.00 190 
    
R2= .19 (Adjusted R2= .16) 
   
 
Obese 
      
Volume of Physical 
Activity 295.52 2 147.76 4.98 0.007 0.03 
Error  10659.54 359 29.69 
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Total  33144.00 368 
    
R2= .23 (Adjusted R2= .21) 
   
       
MS = Mean Square; SS = Sum of squares  
 508 
 509 
 510 
